Grifols acquisition Hologic


Grifols Strengthens Presence In US Where It Now Generates Over 60% Of Sales

Spanish pharmaceutical and healthcare firm Grifols has obtained approval from the US Food and Drug Administration (FDA) to market the physiological saline solution which the company manufactures at its plant in Las Torres de Cotillas (Murcia). This is very positive for the group’s hospital division and, in particular, for its presence in the US.